Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology (Prime GOC)

Abramson Cancer Center at Penn Medicine

Status: Enrolling

Conditions: Lung Cancers; Gastrointestinal Cancers

Treatments: Behavioral: Priming Survey

Study type: Interventional

Funder types: Other

Identifiers

NCT06955468

UPCC 26924

Details and patient eligibility

About

This pilot study will evaluate whether an intervention aimed at hospitalized patients with advanced lung and gastrointestinal cancers can help facilitate goals-of-care (GOC) communication with their oncologists after discharge.

While GOC communication is a recommended component of routine oncology care, many patients with solid cancers do not have the opportunity to talk with their oncologist about their goals and end-of-life preferences. Prior research has shown that a systematic method of prompting GOC communication with at-risk patients would address a key barrier to timely GOC communication and ensure that patients receive care that is in line with their personal preferences.

This trial will enroll 80 participants, who will be randomized 1:1 to either an intervention or a control group. Participants in the intervention group will complete a short survey regarding their goals, preferences, and disease understanding. Survey responses will be shared with each participant's outpatient oncology team. Oncologists will subsequently receive a nudge in the electronic medical record reminding them of key survey responses and encouraging them to discuss them at the patient's first clinic visit after hospital discharge.

The primary feasibility outcome is intervention completion rate and the primary clinical outcome is GOC documentation within 30 days of discharge in the intervention group compared to the control group.

Enrollment: 80 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Unplanned admission to the HUP Solid Oncology service;
2. Underlying diagnosis of advanced lung or GI cancer, defined as metastatic or locally advanced disease;
3. Anticipated discharge within the next 72h; and
4. Primary oncologist is based at HUP; or
5. Family member/caregiver of a patient meeting the above 4 criteria.

Exclusion criteria

1. Unable to complete survey in English.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

80 participants in 2 patient groups

Intervention

Experimental group

Description:

Participants in the intervention arm will complete a survey prior to hospital discharge. Their responses will be shared with each participant's outpatient oncology team.

Treatment:

Behavioral: Priming Survey

Control

No Intervention group